Abstract
Memantine and cholinesterase inhibitors (ChEI) have distinct pharmacological actions, and interest in the use of combination therapy for Alzheimer's disease (AD) is increasing.
Original language | English |
---|---|
Pages (from-to) | 121-125 |
Number of pages | 5 |
Journal | Neuropsychiatric Disease and Treatment |
Volume | 2 |
Issue number | 2 |
DOIs | |
Publication status | Published - Jun 2006 |